Skip to main content

Advertisement

Log in

Evaluation of Matrix Metalloproteinase—2 Expression in Cervical Carcinogenesis Using Tissue Array and Integrated Optical Density for Immunoreactivity

  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

To correlate matrix metalloproteinase—2 (MMP-2) expression with cervical carcinogenesis, the authors use reverse-transcription polymerase chain reaction to detect MMP-2 mRNA expression in 10 cervical squamous cell carcinoma (SCC), 10 high-grade cervical intraepithelial neoplasia (CIN), and 10 normal tissues. They further detect MMP-2 immunoreactivity of 24 tissue cores in each SCC, high-and low-grade CINs, and a healthy subgroup on a tissue array using integrated optical density (IOD) for number and intensity of stained cells in 345 × 345 pixels. They found the mRNA expression of MMP-2 to be higher in most SCCs (9/10 samples) and high-grade CINs (7/10 samples) but lower in normal tissues. The IOD of MMP-2 was significantly higher in high-grade CIN than in normal and low-grade CIN tissue cores (P <.001 for both) and significantly higher in SCC than in high-grade CIN tissue cores (P <.001). The results show that MMP-2 upregulation confers on tumor cells the ability to degrade the subepithelial basement membrane and subsequently invade the cervix.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature Rev Cancer. 2002;2:342–350.

    Article  Google Scholar 

  2. Liotta L. Tumor invasion and metastases: role of the basement membrane. Am J Pathol. 1984;117:339–348.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Liotta L. Tumor invasion and metastases—role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res. 1986;46:1–7.

    Article  CAS  Google Scholar 

  4. Garzetti GG, Ciavattini A., Lucarini G., Goteri G., De Nictolis M., Biagini G. Microinvasive cervical carcinoma and cervical intraepithelial neoplasia: biologic significance and clinical implications of 72-kDa metalloproteinase immunostaining. Gynecol Oncol. 1996;61:197–203.

    Article  CAS  Google Scholar 

  5. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nature Rev. 2002;2:163–176.

    Google Scholar 

  6. Powell WC, Matrisian L. Complex roles of matrix metalloproteinases in tumor progression. In: Günthert U, Birchmeier W, eds. Attempts to Understand Metastasis Formation I. Metastasis-Related Molecules. New York, NY:Springer;1996:1–21.

    Google Scholar 

  7. Silletti S., Raz A. Regulation of autocrine motility factor receptor expression in tumor cell locomotion and metastasis. In: Günthert U, Birchmeier W, eds. Attempts to Understand Metastasis Formation I. Metastasis-Related Molecules. New York, NY:Springer; 1996:22–29.

    Google Scholar 

  8. Stetler-Stevenson WH Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest. 1999;103:1237–1241.

    Article  CAS  PubMed Central  Google Scholar 

  9. Hashimoto G., Inoki I., Fujii Y., Aoki T., Ikeda E., Okada Y. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem. 2002;277:36288–36295.

    Article  CAS  Google Scholar 

  10. Tokuraku M., Sato H., Murakami S., Okada Y., Watanabe Y., Seiki M. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT1-MMP) and with lymph node metastasis. Int J Cancer. 1995;64:355–359.

    Article  CAS  Google Scholar 

  11. Remacle AG, Noel A., Duggan C., et al. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer. Br J Cancer. 1998;77:926–931.

    Article  CAS  PubMed Central  Google Scholar 

  12. Theret N., Musso O., Campion J., et al. Overexpression of matrix metalloproteinase—2 and tissue inhibitor of matrix metalloproteinase-2 in liver from patients with gastrointestinal adenocarcinoma and no detectable metastasis. In J Cancer. 1997;74:426–432.

    CAS  Google Scholar 

  13. Tamakoshi K., Kikkawa F., Nawa A., McDermott E., O’Higgins N., Foidart JM Different pattern of zymography between human gynaecologic normal and malignant tissues. Am J Obstet Gynecol. 1994;171:478–484.

    Article  CAS  Google Scholar 

  14. Ueno H., Yamashita K., Azumano I., Inoue M., Okada Y. Enhanced production and activation of matrix metalloproteinase—7 (matrilysin) in human endometrial carcinomas Int J Cancer. 1999;84:470–477.

    Article  CAS  Google Scholar 

  15. Liotta LA, Tryggvason K., Garbisa S., Hart I., Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980;284:67–71.

    Article  CAS  Google Scholar 

  16. Fessler LI, Duncan KG, Fessler JH, Salo T., Tryggvason K. Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. J Biol Chem. 1984; 259:9783–9789.

    CAS  PubMed  Google Scholar 

  17. Fahey MT, Irwig L., Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol. 1995;141:680–689.

    Article  CAS  Google Scholar 

  18. Nasr M., Ayyad SB, El-Lamie IK, Mikhail MY Expression of matrix metalloproteinase—2 in preinvasive and invasive carcinoma of the uterine cervix. Eur J Gynaecol Oncol. 2005;26:199–202.

    PubMed  Google Scholar 

  19. Perello M., Friedman T., Paez-Espinosa V., Shen X., Stuart RC, Nillni EA Thyroid hormones selectively regulate the post-translational processing of prothyrotropin-releasing hormone in the paraventricular nucleus of the hypothalamus. Endocrinology. 2006;147:2705–2716.

    Article  CAS  Google Scholar 

  20. Emond V., MacLaren LA, Kimmins S., Arosh JA, Fortier MA, Lambert RD Expression of cyclooxygenase-2 and granulocyte-macrophage colony-stimulating factor in the endometrial epithelium of the cow is up-regulated during early pregnancy and in response to intrauterine infusions of interferon-tau. Biol Reprod. 2004;70:54–64.

    Article  CAS  Google Scholar 

  21. Sier CF, Zuidwijk K., Zijlmans HJ, et al. EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma. Int J Cancer. 2006;118:2991–2998.

    Article  CAS  Google Scholar 

  22. Branca M., Ciotti M., Giorgi C., et al. Matrix metalloproteinase—2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN. Anticancer Res. 2006;26:1543–1556.

    CAS  PubMed  Google Scholar 

  23. Levy A., Cioce V., Sobel ME, Garbisa S., Griogioni WF, Liotta LA Increased expression of the 72 kDa type IV collagenase in human colonic adenocarcinoma. Cancer Res. 1991; 51:439–444.

    CAS  PubMed  Google Scholar 

  24. Hoyhtya M., Fridman R., Komarek D., et al. Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissue with monoclonal antibodies. Int J Cancer. 1994;56:500–505.

    Article  CAS  Google Scholar 

  25. Monteagudo C., Merino MJ, SanJuan J, Liotta LA, Stetler Stevenson WJ. Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am J Pathol. 1990;136:585–592.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Sheu BC, Lien HC, Ho HN, et al. Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Cancer Res. 2003;63:6537–6542.

    CAS  PubMed  Google Scholar 

  27. Liotta LA, Tryggvason K., Garbisa S., Hart I., Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980;284:67–68.

    Article  CAS  Google Scholar 

  28. Nair AS, Nair MB, Jayaprakash PG, Rajalekshmy TN, Nair MK, Pillai MR ras and c-myc oncoproteins during tumor progression in the uterine cervix. Tumori. 1998;84:583–588.

    Article  CAS  Google Scholar 

  29. Väisänen A., Tuominen H., Kallioinen M., Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J Pathol. 1996;180:283–289.

    Article  Google Scholar 

  30. Papadopoulou S., Scorilas A., Arnogianaki N., et al. Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa. Tumour Biol. 2001;22:383–389.

    Article  CAS  Google Scholar 

  31. Brummer O., Athar S., Riethdorf L., Löning T., Herbst H. Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study. Virchows Arch. 1999;435:566–573.

    Article  CAS  Google Scholar 

  32. Gaiotto MA, Focchi J., Ribalta JL, et al. Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cells cervical carcinoma. Am J Obstet Gynecol. 2004;190: 1278–1282.

    Article  CAS  Google Scholar 

  33. Jin JS, Hsieh DS, Lin YF, Wang JY, Sheu LF, Lee WH Increasing expression of extracellular matrix metalloproteinase inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters. Int J Urol. 2006;13:573–580.

    Article  CAS  Google Scholar 

  34. Lam JS, Belldegrun AS, Figlin RA Tissue array-based predictions of pathobiology, prognosis and response to treatment for renal cell carcinoma therapy. Clin Cancer Res. 2004;10: 6304–6309.

    Article  Google Scholar 

  35. Hidalgo A., Piña P., Guerrero G., Lazos M., Salcedo M. A simple method for the construction of small format tissue arrays. J Clin Pathol. 2003;56:144–146.

    Article  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Po-Hui Wang MD, PhD.

Additional information

We acknowledge grant support from Chung Shan Medical University (CSMU 95-OM-B-014). We also acknowledge Yi-Chieh Chen and Ken Hsu, who provided kind assistance for the construction and immunohistochemical staining of the cervical tissue array.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tee, YT., Han, CP., Ko, JL. et al. Evaluation of Matrix Metalloproteinase—2 Expression in Cervical Carcinogenesis Using Tissue Array and Integrated Optical Density for Immunoreactivity. Reprod. Sci. 14, 719–726 (2007). https://doi.org/10.1177/1933719107307537

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719107307537

Key words

Navigation